Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2015

Apr 16, 2015

34519_dirs_2015-04-16_50ca3860-4946-4739-b314-4bfb5f64e658.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-12-31

Reporting Person: Brockmann Bobbi Jo (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-05-26 Common Stock, par value $0.10 per share J 49.0000 $4.7100 Acquired 49.0000 Indirect
2011-05-26 Common Stock, par value $0.10 per share J 1006.0000 $4.7400 Acquired 1055.0000 Indirect